Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg
Friday, November 22, 2013 - 8:15am
tags:
Sanofi, Regeneron, rheumatoid arthritis, Sarilumab
New Research And Competition Could Hurt AbbVie's Other Blockbuster
Seeking Alpha
Thursday, November 21, 2013 - 2:05pm
tags:
AbbVie, Auxilium, GSK, Eli Lilly, Androgel
Actavis cutting 30% of U.S. sales organization
Fierce Pharma
Thursday, November 21, 2013 - 1:45pm
tags:
Actavis, layoffs, M&A, Warner Chilcott
The Race For A Cure For Cancer
Seeking Alpha
Thursday, November 21, 2013 - 12:09pm
tags:
cancer, Merck, Bristol-Myers Squibb, Roche, Peregrine Pharmaceuticals
Amicus' 'Transformative' Changes Look More Like Big Step Backward
TheStreet.com
Thursday, November 21, 2013 - 12:07pm
tags:
Amicus Therapeutics, GSK, Sanofi, Biomarin, Callidus Biopharma, Amigal
Next Bard vaginal mesh trial set for December; settlement rumors remain
Fierce Medical Devices
Thursday, November 21, 2013 - 12:06pm
tags:
CR Bard, vaginal mesh, devices
ImmunoVaccine raises $4.2 million in private placement
Reuters
Thursday, November 21, 2013 - 12:04pm
tags:
Immunovaccine
Cardiome's Brinavess shows positive results in cardiological publication
The Fly on the Wall
Thursday, November 21, 2013 - 12:01pm
tags:
Cardiome, Brinavess, atrial fibrillation
Pfizer’s XALKORI® Granted Regular FDA Approval
Yahoo
Thursday, November 21, 2013 - 11:59am
tags:
Pfizer, Xalkori, non-small cell lung cancer
With News of an Investigation, Is This Still an Attractive Biotech Stock?
Motley Fool
Thursday, November 21, 2013 - 11:14am
tags:
Questcor Pharmaceuticals, Acthar
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thursday, November 21, 2013 - 11:05am
tags:
Amgen, evolocumab, PCSK9 inhibitors, cholesterol, Talimogene Laherparepvec
BioMarin Seen Luring $13 Billion Takeover Bid: Real M&A
Bloomberg
Thursday, November 21, 2013 - 11:00am
tags:
Biomarin, M&A
Two Dozen Drugmakers Pay $88M To Louisiana Over Inflated Prices
Pharmalot
Thursday, November 21, 2013 - 10:11am
tags:
Louisiana, drug pricing, Novartis, Sanofi, JNJ, Par Pharmaceutical, Ranbaxy, Abbott Laboratories
2 Small Speculative Biotech Plays Moving On News
Seeking Alpha
Thursday, November 21, 2013 - 10:08am
tags:
Inovio, Oncolytics
The New Cholesterol Guidelines And Conflicts Of Interest
Forbes
Thursday, November 21, 2013 - 8:35am
tags:
American Heart Association, cholesterol, heart disease, statins, conflict-of-interest
Pfizer Inc. to close one of its 3 pharmaceutical manufacturing plants in Puerto Rico by 2017
Yahoo/AP
Thursday, November 21, 2013 - 8:32am
tags:
Pfizer, drug manufacturing, Puerto Rico
Will Recent News Hurt Johnson & Johnson?
Wall St Cheat Sheet
Thursday, November 21, 2013 - 8:32am
tags:
JNJ
Aphios Spins off Amylon LLC to Develop Novel Alzheimer's Disease Drug
4-Traders.com
Thursday, November 21, 2013 - 8:29am
tags:
Aphios, Amylon, Alzheimer's disease, APH-1104
FDA declines to approve new Forest, Richter drug
Reuters
Thursday, November 21, 2013 - 8:27am
tags:
FDA, Forest Labs, Geodon Richter, cariprazine
Pfizer, Glaxo to initiate study of combination therapy in patients with melanoma
The Fly on the Wall
Thursday, November 21, 2013 - 8:25am
tags:
GSK, Pfizer, melanoma, trametinib, palbociclib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.